|
| 
|
|
|
|
 |
|
 |
|
|
|
 |
FEATURES |
 |
|
|
|
|
 |
Australia, biotech's destination next
 |
|
| Located in the southern hemisphere, Australia, officially known as the Commonwealth of Australia, is striving to become the well-established destination for biotechnology. Its government has a vision to become one of the top five global locations |
|
|
|
|
|
|
 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R & D |
|
|
|
|
|
|
Ondek starts first human trial of life saving oral vaccines
|
|
| Ondek, an Australian biotechnology company, founded by Prof Barry Marshall, an Australian who won a Nobel Prize for discovering the bacteria that causes stomach ulcers has launched the first human clinical trial to see if the same bugs can be used |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
POLICIES |
|
|
|
|
Mesoblast gets US patent for bone repair products
|
|
| Australia's regenerative medicine company, Mesoblast said that the US Patent and Trademark Office has granted a key patent that provides exclusive commercial protection for its bone tissue generating products in the US |
|
|
|
|
|
DispersinB gets Australian patent
|
|
| Kane Biotech, a biotechnology company developing products that prevent and disperse microbial biofilms, has received patent No. 2003284385 entitled Compositions and methods for enzymatic detachment of bacterial and fungal biofilms by IP Australia |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
